TABLE 1.
Characteristic | Value for: |
|||
---|---|---|---|---|
10-Day challenge |
90-Day challenge |
|||
Vaccine (n = 26) | Placebo (n = 22) | Vaccine (n = 20) | Placebo (n = 16) | |
Mean age, yr (SD) | 31.3 (5.9) | 31.6 (7.8) | 34.8 (8.1) | 30.6 (6.4) |
Sex, no. (%) | ||||
Male | 17 (65.4) | 11 (50.0) | 14 (70.0) | 10 (62.5) |
Female | 9 (34.6) | 11 (50.0) | 6 (30.0) | 6 (37.5) |
Race, no. (%) | ||||
Black/African-American | 14 (53.9) | 13 (59.1) | 14 (70.0) | 12 (75.0) |
White | 8 (30.8) | 9 (40.9) | 6 (30.0) | 4 (25.0) |
Other | 4 (15.3) | 0 | 0 | 0 |
Blood group, no. (%) | ||||
O | 11 (42.3) | 12 (54.5) | 13 (65.0) | 6 (37.5) |
Non-O | 15 (57.7) | 10 (45.5) | 7 (35.0) | 10 (62.5) |